By: William M. Buchholz, M.D.

As I ate breakfast one morning, I overheard two oncologists conversing. One complained bitterly, “You know, Bob, I just don’t understand it.

We used the same drugs, the same dosage, the same schedule and the same entry criteria. Yet I got a 22 percent response rate and you got a 74 percent. That’s unheard of for metastatic cancer. How do you do it?”

His colleague replied, “We’re both using Etoposide, Platinum, Oncovin and Hydroxyurea. You call yours EPOH. I tell my patients I’m giving them HOPE. As dismal as the statistics are, I emphasize that we have a chance.”

No related posts.

 Leave a Reply

(required)

(required)

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>